LeMaitre Vascular (NSDQ:LMAT) posted third-quarter results that beat the consensus forecast on Wall Street. The Burlington, Mass.-based company reported profits of $7.5 million, or 37¢ per share, on sales of $36.4 million for the three months ended Sept. 30, for a bottom-line gain of 44.9% sales growth of 25.1% compared with Q3 2019. Earnings per share […]
LeMaitre Vascular Inc.
MedTech 100 roundup: Markets dip again
Medtech stocks continue to fluctuate amid the COVID-19 pandemic, with a significant dip in the shares belonging to the industry’s biggest names. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 81.88 points at the end of last week (June 26). That total represents a -3.7% decrease […]
LeMaitre Vascular acquires Artegraft
LeMaitre Vascular (NSDQ:LMAT) announced that it acquired the business and assets of Artegraft in a deal worth $90 million. Under the terms of the acquisition, LeMaitre will pay $72.5 million in cash at closing, with $65 million for Artegraft, plus $7.5 million in escrow to be released on Dec. 31, 2021. There is an additional $17.5 […]
LeMaitre Vascular shares down on in line Q1 results
LeMaitre Vascular (NSDQ:LMAT) posted first-quarter results that met the consensus forecast on Wall Street. The company reported profits of $3.2 million, or 16¢ per share, on sales of $30.5 million for the three months ended March 31, for a bottom-line loss of -9.6% sales growth of 7.3% compared with Q1 2019. Earnings per share were 16¢, […]
LeMaitre Vascular recall of embolectomy catheters is Class I
The FDA identified the recall of LeMaitre Vascular (NSDQ:LMAT) Over the Wire embolectomy catheters for a failure to deflate as a Class I recall. Burlington, Mass.–based LeMaitre Vascular’s Over the Wire embolectomy catheter is indicated for use in the surgical removal of blood clots that are lodged in a blood vessel (emboli) and blood clots that form […]
LeMaitre Vascular takes a big hit on 4Q slide
LeMaitre Vascular (NSDQ:LMAT) shares plummetted today on fourth-quarter results that came up shy of the consensus forecast and revealed a big dip in profits. The Burlington, Mass.–based maker of peripheral vascular disease devices posted profits of $4.6 million, or 23¢ per share, on sales of $30.2 million for the three months ended Dec. 31, 2019, for […]
Admedus deals biologic patch business to LeMaitre Vascular for $24m
Admedus (ASX:AHZ) dealt its biologic patch business to LeMaitre Vascular (NSDQ:LMAT) in a deal worth up to $24.6 million to focus on the transcatheter aortic valve replacement market. The A$36.2 million buyout of the CardioCel and VascuCel patches called for LeMaitre to put up $14.2 million up front, with another $1.4 million due in a pair […]
LeMaitre Vascular puts up $2m for BD’s Cardial
LeMaitre Vascular (NSDQ:LMAT) said today it inked a deal to acquire Becton Dickinson‘s (NYSE:BDX) Cardial subsidiary for approximately $2.3 million (EU €2 million). The Saint-Étienne, France-based subsidiary produces knitted and woven vascular grafts, valvulotomes and surgical glue, and reported approximately $3.3 million (EU €2.9 million) in sales over the past 12 months, Burlington, Mass.-based LeMaitre said. […]
LeMaitre Vascular ponies up $14m for Applied Medical’s clot management tech
LeMaitre Vascular (NSDQ:LMAT) this week ponied up $11 million in cash and another $3 million in post-closing payments for the vascular clot business at Applied Medical Resources Corp. The Burlington, Mass.-based company said the $14.2 million deal includes a one-year transition services provision that will see Applied Medical manufacture the devices for LeMaitre. The deal covers […]
LeMaitre Vascular shares down on Q2 sales miss
Shares in LeMaitre Vascular (NSDQ:LMAT) have fallen slightly after the medical device maker missed sales expectations but met earnings per share consensus on Wall Street with its second quarter earnings results. The Burlington, Mass.-based company posted profits of $8.8 million, or 43¢ per share, on sales of $27 million for the three months ended June 30, […]
LeMaitre Vascular deals Reddick surgical assets to Symmetry for $7m
LeMaitre Vascular (NSDQ:LMAT) said yesterday that it agreed to deal its Reddick general surgery assets to Symmetry Surgical for more than $7 million. The deal includes Burlington, Mass.-based LeMaitre’s Reddick cholangiogram catheter and Reddick-Saye screw for laparoscopic cholecystectomies and a two-year manufacturing transition pact. LeMaitre said the gen-surg product line it’s selling put up revenues of $3.3 […]
